Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.285 USD | -10.25% | -12.43% | -2.07% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.07% | 138M | |
+29.52% | 49.18B | |
+0.88% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.67% | 26.09B | |
-22.87% | 18.71B | |
+8.16% | 13.26B | |
+32.32% | 12.32B | |
-0.72% | 11.99B |
- Stock Market
- Equities
- VIGL Stock
- News Vigil Neuroscience, Inc.
- Vigil Neuroscience Says First Participant Dosed in Phase 1 Trial of Potential Alzheimer's Disease Treatment